Hepatitis B and D Protocols: Volume 2: Immunology, Model Systems, and Clinical Studies (Methods in Molecular Medicine) by Robert K. Hamatake
English | November 9, 2010 | ISBN: 161737363X | 549 pages | PDF | 6 MB
Despite the availability of an effective vaccine, there are still 400 million people, worldwide who are chronically infected with hepatitis B virus (HBV). For them, the vaccine, as currently applied, has no value. Given the possible consequences of HBV infection, the number of those chronically infected with HBV presents an enormous public health challenge.